Général
Code
AZGS2024078
Nom
SWIFT
Description
Study of the efficacy and safety of the drug GS-1427 in adults with moderately to severely active ulcerative colitis. Different doses of the drug are being compared with placebo in a double-blind, randomized design.
Début de la période d'inclusion
01/04/2025
Contact
Coordinateur
Sarah Heugebaert
Téléphone
056633339
Mail
sarah.heugebaert@azgroeninge.be